Search

everythinglearnresearchcommunity

for

Search:↓

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Apremilast did not work for treating severe alopecia areata.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Children with autoimmune gastritis showed improved intestinal health over time and should be checked for other autoimmune conditions.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

ILC1 cells contribute to hair loss in alopecia areata.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Nanotechnology could improve treatment for scars and atopic dermatitis by targeting skin issues more effectively.

Baricitinib is effective and safe for treating severe alopecia areata.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Topical corticosteroids are the preferred first treatment for children with Alopecia Areata.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

More research is needed to understand and manage rheumatoid arthritis better.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.